These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35452676)

  • 1. Antibody recognition of complement factor H reveals a flexible loop involved in atypical hemolytic uremic syndrome pathogenesis.
    Yokoo T; Tanabe A; Yoshida Y; Caaveiro JMM; Nakakido M; Ikeda Y; Fujimura Y; Matsumoto M; Entzminger K; Maruyama T; Okumura CJ; Nangaku M; Tsumoto K
    J Biol Chem; 2022 Jun; 298(6):101962. PubMed ID: 35452676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
    Bhattacharjee A; Reuter S; Trojnár E; Kolodziejczyk R; Seeberger H; Hyvärinen S; Uzonyi B; Szilágyi Á; Prohászka Z; Goldman A; Józsi M; Jokiranta TS
    J Biol Chem; 2015 Apr; 290(15):9500-10. PubMed ID: 25659429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological features and functional analysis of anti-CFH autoantibodies in patients with atypical hemolytic uremic syndrome.
    Guo WY; Song D; Liu XR; Chen Z; Xiao HJ; Ding J; Sun SZ; Liu HY; Wang SX; Yu F; Zhao MH;
    Pediatr Nephrol; 2019 Feb; 34(2):269-281. PubMed ID: 30315407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation.
    Kerr H; Wong E; Makou E; Yang Y; Marchbank K; Kavanagh D; Richards A; Herbert AP; Barlow PN
    J Biol Chem; 2017 Aug; 292(32):13345-13360. PubMed ID: 28637873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH
    Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual case of adult-onset still's disease complicated with anti-complement factor H antibodies associated atypical haemolytic uraemic syndrome.
    Fung WW; Chao AC; Pang WF; Wong RS; Chow KM; Szeto CC
    BMC Nephrol; 2024 May; 25(1):164. PubMed ID: 38745129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
    Rigothier C; Delmas Y; Roumenina LT; Contin-Bordes C; Lepreux S; Bridoux F; Goujon JM; Bachelet T; Touchard G; Frémeaux-Bacchi V; Combe C
    Am J Kidney Dis; 2015 Aug; 66(2):331-6. PubMed ID: 26015278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
    Hofer J; Janecke AR; Zimmerhackl LB; Riedl M; Rosales A; Giner T; Cortina G; Haindl CJ; Petzelberger B; Pawlik M; Jeller V; Vester U; Gadner B; van Husen M; Moritz ML; Würzner R; Jungraithmayr T;
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):407-15. PubMed ID: 23243267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome.
    Strobel S; Hoyer PF; Mache CJ; Sulyok E; Liu WS; Richter H; Oppermann M; Zipfel PF; Józsi M
    Nephrol Dial Transplant; 2010 Jan; 25(1):136-44. PubMed ID: 19666655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.
    Valoti E; Alberti M; Tortajada A; Garcia-Fernandez J; Gastoldi S; Besso L; Bresin E; Remuzzi G; Rodriguez de Cordoba S; Noris M
    J Am Soc Nephrol; 2015 Jan; 26(1):209-19. PubMed ID: 24904082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan.
    Yoshida Y; Miyata T; Matsumoto M; Shirotani-Ikejima H; Uchida Y; Ohyama Y; Kokubo T; Fujimura Y
    PLoS One; 2015; 10(5):e0124655. PubMed ID: 25951460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function.
    Fujisawa M; Yasumoto A; Kato H; Sugawara Y; Yoshida Y; Yatomi Y; Nangaku M
    Br J Haematol; 2020 Apr; 189(1):182-186. PubMed ID: 31879952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation.
    Kim S; Park E; Min SI; Yi NJ; Ha J; Ha IS; Cheong HI; Kang HG
    J Korean Med Sci; 2018 Jan; 33(1):e4. PubMed ID: 29215813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome.
    Hyvärinen S; Uchida K; Varjosalo M; Jokela R; Jokiranta TS
    J Biol Chem; 2014 Feb; 289(7):4295-306. PubMed ID: 24344133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2019; 10():853. PubMed ID: 31118930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-complement factor H (CFH) antibodies and a novel
    Minato S; Iijima H; Nakao H; Nishi K; Hidaka Y; Inoue N; Kubota M; Ishiguro A
    Immunol Med; 2021 Dec; 44(4):274-277. PubMed ID: 33784485
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Piras R; Valoti E; Alberti M; Bresin E; Mele C; Breno M; Liguori L; Donadelli R; Rigoldi M; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2022; 13():1011580. PubMed ID: 36793547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: A family of atypical hemolytic uremic syndrome involving a
    Tasaki Y; Tsujimoto H; Yokoyama T; Sugimoto N; Kitajima S; Fujii H; Hidaka Y; Kato N; Maruyama S; Inoue N; Wada T
    Front Immunol; 2024; 15():1360855. PubMed ID: 38524137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Factor H Antibody-Associated Atypical Hemolytic Uremic Syndrome: A Case Report.
    Abazi-Emini N; Sahpazova E; Putnik J; Tasic V
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Oct; 42(2):109-115. PubMed ID: 34699711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.